BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Zheng L, Yan M, Wu J, Liu Y, Tian X, Jiang W, Zhang L, Wang R. Activity and mechanism of flavokawain A in inhibiting P-glycoprotein expression in paclitaxel resistance of lung cancer. Oncol Lett 2020;19:379-87. [PMID: 31897150 DOI: 10.3892/ol.2019.11069] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu S, Liu Z, Piao C, Zhang Z, Kong C, Yin L, Liu X. Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer. J Exp Clin Cancer Res 2022;41:293. [PMID: 36199122 DOI: 10.1186/s13046-022-02500-4] [Reference Citation Analysis]
2 Soares RB, Dinis-oliveira RJ, Oliveira NG. An Updated Review on the Psychoactive, Toxic and Anticancer Properties of Kava. JCM 2022;11:4039. [DOI: 10.3390/jcm11144039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ouyang Y, Li J, Chen X, Fu X, Sun S, Wu Q. Chalcone Derivatives: Role in Anticancer Therapy. Biomolecules 2021;11:894. [PMID: 34208562 DOI: 10.3390/biom11060894] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 13.5] [Reference Citation Analysis]
4 Michalkova R, Mirossay L, Gazdova M, Kello M, Mojzis J. Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones. Cancers (Basel) 2021;13:2730. [PMID: 34073042 DOI: 10.3390/cancers13112730] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
5 Yang R, Chen Z, Xie F, Xie M, Liu N, Su Z, Gu J, Zhao R. (+/-)-Borneol Reverses Mitoxantrone Resistance against P-Glycoprotein. J Chem Inf Model 2021;61:252-62. [PMID: 33378196 DOI: 10.1021/acs.jcim.0c00892] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
6 Bian T, Corral P, Wang Y, Botello J, Kingston R, Daniels T, Salloum RG, Johnston E, Huo Z, Lu J, Liu AC, Xing C. Kava as a Clinical Nutrient: Promises and Challenges. Nutrients 2020;12:E3044. [PMID: 33027883 DOI: 10.3390/nu12103044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
7 Li J, Zheng L, Wang R, Sun D, Liang S, Wu J, Liu Y, Tian X, Li T, Yang Y, Han L. Synergistic Combination of Sodium Aescinate-Stabilized, Polymer-Free, Twin-Like Nanoparticles to Reverse Paclitaxel Resistance. Int J Nanomedicine 2020;15:5839-53. [PMID: 32848393 DOI: 10.2147/IJN.S259432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]